HEALTH

PROTEUS Substudy Reports 63% of Prostate Cancer Patients Avoid Recurrence With Combination Therapy

NaturalNews.com — October 29, 2026 at 10:22 PM UTC

■ Source Bias Analysis 5 ratings found

LEFTLEAN LEFTCENTERLEAN RIGHTRIGHT

MBFC CONSPIRACY Factual: MIXED

AllSides RIGHT Confidence: high

Ad Fontes FAR RIGHT Reliability: 8.7/64

Ground News RIGHT

Wikipedia BLACKLISTED Natural News

CONSENSUS: Right

▶ View on Ground News →

PROTEUS Substudy Reports 63% of Prostate Cancer Patients Avoid Recurrence With Combination Therapy

(NaturalNews) A substudy of the PROTEUS trial found that 63% of men who received the hormone therapy apalutamide plus androgen-deprivation therapy before and after ...

READ MORE AT SOURCE »

Originally reported by NaturalNews.com

HOW DO YOU SEE THIS STORY?

Choose your pill. Your vote is anonymous.

0 TOTAL VOTES

SCAN TO SHARE

« Back to The Culture War